Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

A Study to Learn How Different Amounts of the Study Medicine Called PF-07328948 Are Tolerated and Act in the Body in Healthy AdultsCompleted
NCT05807490Phase 1Updated Jul 19, 2024
Sponsor: Pfizer
Healthy
United States, Belgium
Global Prevalence of ATTR-CM in Participants With HFpEFTerminated
NCT04424914NAUpdated Jul 19, 2024
Sponsor: Pfizer
Transthyretin Amyloid Cardiomyopathy · Heart Failure With Preserved Ejection Fraction
United States, Canada, France, Italy, Japan +3 more
Steroid-reducing Effects of CrisaboroleCompleted
NCT03832010Phase 4Updated Jul 19, 2024
Sponsor: Johns Hopkins University
Atopic Dermatitis · Eczema
United States
A Study to Learn How the Body Processes the Study Medicine Called PF-07923568 in People With Loss of Kidney FunctionCompleted
NCT06037031Phase 1Updated Jul 19, 2024
Sponsor: Pfizer
Renal Impairment
United States
Treatment Patterns With Targeted Therapies In Mrcc In Sweden - A Retrospective Analysis Of Data From National RegistriesCompleted
NCT04669366N/AUpdated Jul 19, 2024
Sponsor: Pfizer
Kidney Neoplasms
Sweden
A Low-Interventional Study of an Electronic Sickle Cell Disease Patient Reported Outcomes in Sickle Cell ParticipantsTerminated
NCT06503458N/AUpdated Jul 16, 2024
Sponsor: Sanguine Biosciences
Sickle Cell Disease · Sickle Cell Anemia
United States
Avelumab in Relapsed and Refractory Peripheral T-cell LymphomaCompleted
NCT03046953Phase 2Updated Jul 16, 2024
Sponsor: University of Birmingham
T-Cell Lymphoma Relapsed · T-Cell Lymphoma Refractory
United Kingdom
Pivotal Bioequivalence Study to Qualify Manufacturing Site Transfer for Prazosin Hydrochloride CapsulesCompleted
NCT04967443Phase 1Updated Jul 12, 2024
Sponsor: Pfizer
Hypertension · Heart Failure
United States
Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue SarcomasCompleted
NCT02636725Phase 2Updated Jul 12, 2024
Sponsor: Jonathan Trent, MD, PhD
Alveolar Soft Part Sarcoma · Soft Tissue Sarcomas
United States
Safety and Effectiveness of Apixaban Compared to Warfarin in Patients With Non-valvular Atrial Fibrillation (a Type of Irregular Heart Rhythm) at Higher Chance of BleedingCompleted
NCT05471505N/AUpdated Jul 11, 2024
Sponsor: Pfizer
Non-valvular Atrial Fibrillation
Japan
Temsirolimus for Relapsed/Refractory Hodgkin's LymphomaTerminated
NCT00838955Phase 2Updated Jul 10, 2024
Sponsor: Loyola University
Hodgkin's Lymphoma
United States
A First in HumanTrial to Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-06755347Terminated
NCT03275740Phase 1Updated Jul 5, 2024
Sponsor: Pfizer
Healthy · Primary Immune Thrombocytopenia · Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
United States, Belgium, New Zealand, Spain, United Kingdom
Study Evaluating Single Dose Of ILV-095 In Psoriasis SubjectsTerminated
NCT01010542Phase 1Updated Jul 3, 2024
Sponsor: Pfizer
Plaque Psoriasis
United States, Canada
Safety and Efficacy of Axicabtagene Ciloleucel in Combination With Utomilumab in Adults With Refractory Large B-cell LymphomaTerminated
NCT03704298Phase 1Updated Jun 28, 2024
Sponsor: Kite, A Gilead Company
Relapsed/Refractory Large B-cell Lymphoma
United States
Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to FollowTerminated
NCT00330564Phase 2Updated Jun 27, 2024
Sponsor: M.D. Anderson Cancer Center
Von Hippel-Lindau Syndrome · Renal Cell Carcinoma · Hemangioblastoma
United States
Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia AreataCompleted
NCT04556734Phase 2Updated Jun 26, 2024
Sponsor: Pfizer
Alopecia Areata
United States, Canada
Crizotinib (Xalkori) Expanded Access Protocol For The Treatment Of Adult Or Pediatric PatientsNo Longer Available
NCT02473497N/AUpdated Jun 26, 2024
Sponsor: Pfizer
Neoplasm
United States
PF-06952229 Treatment in Adult Patients With Advanced Solid TumorsTerminated
NCT03685591Phase 1Updated Jun 26, 2024
Sponsor: Pfizer
Breast Neoplasms · Prostate Neoplasms · Neoplasms, Squamous Cell · Melanoma
United States
A Study to Learn How Different Forms of Study Medicine Tafamidis Are Taken Up Into The Blood in Healthy AdultsCompleted
NCT06273839Phase 1Updated Jun 26, 2024
Sponsor: Pfizer
Healthy
Belgium
Hepatic Impairment Study for Lorlatinib in Cancer PatientsTerminated
NCT03726333Phase 1Updated Jun 21, 2024
Sponsor: Pfizer
Advanced Cancers
United States
Real-World Observational Study Of Zavicefta to Characterize Use PatternsCompleted
NCT03923426N/AUpdated Jun 21, 2024
Sponsor: Pfizer
Infection
Argentina, Austria, Brazil, Colombia, France +6 more
Special Investigation of COMIRNATY in the Population With Underlying DiseasesCompleted
NCT04880447N/AUpdated Jun 21, 2024
Sponsor: Pfizer
COVID-19
Japan
An Active Surveillance, Post-Authorization Study to Characterize the Safety of Tofacitinib in Patients With Moderately to Severely Active Ulcerative Colitis in the Real-World Setting Using Data From the United Registries for Clinical Assessment and Research (UR-CARE) in the European Union (EU)Unknown
NCT06469424N/AUpdated Jun 21, 2024
Sponsor: Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
Ulcerative Colitis
Belgium, Bulgaria, Greece, Lithuania
The Safety And Efficacy Of Sunitinib In Chinese Patients With Progressive Advanced Or Metastatic Well-Differentiated Unresectable Pancreatic Neuroendocrine TumorsCompleted
NCT02282059N/AUpdated Jun 20, 2024
Sponsor: Pfizer
Pancreatic Neuroendocrine Tumors
China
Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic PatientsWithdrawn
NCT00304772Phase 4Updated Jun 14, 2024
Sponsor: Kyoto University
Candidiasis · Sepsis
Japan

Previous page Next page